Shexiang Tongxin Dripping Pills regulates SOD/TNF-α/IL-6 pathway to inhibit inflammation and oxidative stress to improve myocardial ischemia-reperfusion injury in mice.

IF 2.8 3区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Frontiers in Cardiovascular Medicine Pub Date : 2025-06-12 eCollection Date: 2025-01-01 DOI:10.3389/fcvm.2025.1571925
Wanying Du, Chenguang Zhai, Huijie Zhang, Jun Ren, Xiaoyang Chen, Xuejing Sun, Chun Li, Wei Wang, Yijun Chen
{"title":"Shexiang Tongxin Dripping Pills regulates SOD/TNF-α/IL-6 pathway to inhibit inflammation and oxidative stress to improve myocardial ischemia-reperfusion injury in mice.","authors":"Wanying Du, Chenguang Zhai, Huijie Zhang, Jun Ren, Xiaoyang Chen, Xuejing Sun, Chun Li, Wei Wang, Yijun Chen","doi":"10.3389/fcvm.2025.1571925","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Shexiang Tongxin Dropping Pills (STDP), a traditional Chinese medicine (TCM), is clinically used for cardiovascular diseases like myocardial ischemia. Myocardial ischemia-reperfusion injury (MIRI), worsened by oxidative stress and inflammation, remains a significant problem, and the mechanisms underlying STDP's cardioprotection are incompletely understood. This study aimed to investigate STDP's effects on the SOD/TNF-α/IL-6 pathway and its impact on inflammation and oxidative stress in MIRI.</p><p><strong>Methods: </strong>A mouse model of MIRI was employed to evaluate the cardioprotective effects and mechanisms of STDP <i>in vivo</i>. Pretreatment with STDP was administered prior to MIRI induction. Assessments included serum SOD activity, cardiac tissue ROS levels, cardiomyocyte apoptosis rates (TUNEL assay), mRNA and protein expression of IL-1β, TNF-α, and IL-6 (qPCR, Western blot), histopathological evaluation of myocardial tissue morphology and inflammatory infiltration (H&E staining), myocardial infarction size (TTC staining), and cardiac function parameters (contractility, diastolic function).</p><p><strong>Results: </strong>STDP pretreatment significantly enhanced serum SOD activity and reduced cardiac ROS levels and cardiomyocyte apoptosis. It effectively downregulated mRNA and protein expression of IL-1β, TNF-α, and IL-6. Histopathology revealed reduced inflammatory cell infiltration and more intact cardiomyocyte morphology in STDP-treated groups. TTC staining confirmed a reduction in myocardial infarction size. Cardiac function assessments showed STDP improved both contractility and diastolic function post-MIRI and reduced arrhythmia incidence.</p><p><strong>Discussion: </strong>STDP ameliorates MIRI in mice by inhibiting inflammatory responses and oxidative stress, primarily through modulation of the SOD/TNF-α/IL-6 pathway. Its cardioprotective effects include reducing apoptosis, inflammation, ROS, infarction size, and arrhythmias, while improving cardiac function and tissue repair. These findings elucidate a key mechanism for STDP and provide empirical support for its clinical use in MIRI, offering innovative perspectives for managing cardiovascular disorders with TCM and facilitating the integration of traditional and modern medicine.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"12 ","pages":"1571925"},"PeriodicalIF":2.8000,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12198137/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Cardiovascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fcvm.2025.1571925","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Shexiang Tongxin Dropping Pills (STDP), a traditional Chinese medicine (TCM), is clinically used for cardiovascular diseases like myocardial ischemia. Myocardial ischemia-reperfusion injury (MIRI), worsened by oxidative stress and inflammation, remains a significant problem, and the mechanisms underlying STDP's cardioprotection are incompletely understood. This study aimed to investigate STDP's effects on the SOD/TNF-α/IL-6 pathway and its impact on inflammation and oxidative stress in MIRI.

Methods: A mouse model of MIRI was employed to evaluate the cardioprotective effects and mechanisms of STDP in vivo. Pretreatment with STDP was administered prior to MIRI induction. Assessments included serum SOD activity, cardiac tissue ROS levels, cardiomyocyte apoptosis rates (TUNEL assay), mRNA and protein expression of IL-1β, TNF-α, and IL-6 (qPCR, Western blot), histopathological evaluation of myocardial tissue morphology and inflammatory infiltration (H&E staining), myocardial infarction size (TTC staining), and cardiac function parameters (contractility, diastolic function).

Results: STDP pretreatment significantly enhanced serum SOD activity and reduced cardiac ROS levels and cardiomyocyte apoptosis. It effectively downregulated mRNA and protein expression of IL-1β, TNF-α, and IL-6. Histopathology revealed reduced inflammatory cell infiltration and more intact cardiomyocyte morphology in STDP-treated groups. TTC staining confirmed a reduction in myocardial infarction size. Cardiac function assessments showed STDP improved both contractility and diastolic function post-MIRI and reduced arrhythmia incidence.

Discussion: STDP ameliorates MIRI in mice by inhibiting inflammatory responses and oxidative stress, primarily through modulation of the SOD/TNF-α/IL-6 pathway. Its cardioprotective effects include reducing apoptosis, inflammation, ROS, infarction size, and arrhythmias, while improving cardiac function and tissue repair. These findings elucidate a key mechanism for STDP and provide empirical support for its clinical use in MIRI, offering innovative perspectives for managing cardiovascular disorders with TCM and facilitating the integration of traditional and modern medicine.

麝香通心滴丸通过调节SOD/TNF-α/IL-6通路抑制炎症和氧化应激,改善小鼠心肌缺血再灌注损伤。
简介:麝香通心滴丸(STDP)是一种中药,临床上用于治疗心肌缺血等心血管疾病。心肌缺血-再灌注损伤(MIRI)由氧化应激和炎症恶化,仍然是一个重要的问题,STDP的心脏保护机制尚不完全清楚。本研究旨在探讨STDP对MIRI中SOD/TNF-α/IL-6通路的影响及其对炎症和氧化应激的影响。方法:采用小鼠MIRI模型,在体内评价STDP的心脏保护作用及其机制。在诱导MIRI之前使用STDP进行预处理。评估方法包括血清SOD活性、心肌组织ROS水平、心肌细胞凋亡率(TUNEL法)、IL-1β、TNF-α、IL-6 mRNA和蛋白表达(qPCR、Western blot)、心肌组织形态和炎症浸润(H&E染色)、心肌梗死大小(TTC染色)、心功能参数(收缩力、舒张功能)的组织病理学评价。结果:STDP预处理可显著提高血清SOD活性,降低心肌ROS水平和心肌细胞凋亡。有效下调IL-1β、TNF-α和IL-6的mRNA和蛋白表达。组织病理学显示,stdp治疗组炎症细胞浸润减少,心肌细胞形态更完整。TTC染色证实心肌梗死面积减小。心功能评估显示,STDP改善了miri后的收缩力和舒张功能,降低了心律失常的发生率。讨论:STDP通过抑制炎症反应和氧化应激,主要通过调节SOD/TNF-α/IL-6途径,改善小鼠MIRI。其心脏保护作用包括减少细胞凋亡、炎症、ROS、梗死面积和心律失常,同时改善心功能和组织修复。这些发现阐明了STDP的关键机制,为其在MIRI中的临床应用提供了实证支持,为中医药管理心血管疾病和促进传统与现代医学的结合提供了创新视角。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Cardiovascular Medicine
Frontiers in Cardiovascular Medicine Medicine-Cardiology and Cardiovascular Medicine
CiteScore
3.80
自引率
11.10%
发文量
3529
审稿时长
14 weeks
期刊介绍: Frontiers? Which frontiers? Where exactly are the frontiers of cardiovascular medicine? And who should be defining these frontiers? At Frontiers in Cardiovascular Medicine we believe it is worth being curious to foresee and explore beyond the current frontiers. In other words, we would like, through the articles published by our community journal Frontiers in Cardiovascular Medicine, to anticipate the future of cardiovascular medicine, and thus better prevent cardiovascular disorders and improve therapeutic options and outcomes of our patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信